Modulators of cystic fibrosis transmembrane conductance regulator
US8969382B2 · kind B2 · utility
63Cited by
2References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 7, 2013 |
| Grant date | Mar 3, 2015 |
| Priority date | — |
| Expiry date | Nov 7, 2033 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/55
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to modulators of cystic fibrosis transmembrane conductance regulator (“CFTR”), compositions thereof, and methods therewith. The present invention also relates to methods of treating diseases using modulators of CFTR.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.